Core Viewpoint - The recent surge in stock price of Joyoung Co., Ltd. (九阳股份) was driven by market speculation related to a product named "Hachimi North and South Soy Milk," which is not produced by the company but by a separate entity, leading to a misinterpretation by investors [2][3][4]. Group 1: Stock Price Movement - Joyoung's stock price experienced consecutive trading halts, reaching 11.06 yuan per share on November 13, 2023, and continued to rise on November 14, 2023 [3]. - The stock surge was fueled by a misunderstanding regarding the association with the "Hachimi" product, which is operated by Hangzhou Joyoung Soybean Products Co., Ltd., a company that Joyoung has no current equity relationship with [4][6]. Group 2: Company Clarification - On November 13, 2023, Joyoung clarified on an interactive platform that it does not have any products related to "Hachimi," and it has no plans to reacquire the soy milk brand [3][6]. - Joyoung officially divested all its shares in Hangzhou Joyoung Soybean Products Co., Ltd. in December 2023, fully separating from the soy milk business to focus on small home appliances [7]. Group 3: Financial Performance - For the first three quarters of 2023, Joyoung reported a total revenue of 5.585 billion yuan, a year-on-year decrease of 9.66%, while achieving a net profit of 124 million yuan, an increase of 26.03% [8]. - The company's non-recurring net profit reached 192 million yuan, up 48.17% year-on-year, with a gross margin of 26.92%, reflecting a 0.65 percentage point increase [8]. - In Q3 2023, Joyoung's revenue was 1.598 billion yuan, down 10.99% year-on-year, but the net profit showed significant growth of 101.11% [8].

Market Overview - The Hang Seng Index fell by 1.26%, down 340 points, closing at 26,732 points, while the Hang Seng Tech Index dropped by 2.20% [1] - Early trading volume in the Hong Kong stock market reached HKD 125 billion [1] Hydrogen Energy Sector - The hydrogen energy sector experienced significant gains following the National Energy Administration's encouragement of green hydrogen utilization in coal chemical projects [1] - Reshaping Energy (02570) surged over 55% [1] - Guofu Hydrogen Energy (02582) rose over 11% [1] - Guohong Hydrogen Energy (09663) increased by over 5% [1] - Yihua Tong (02402) saw a rise of 6.8% [1] Pharmaceutical Sector - Basestone Pharmaceuticals-B (02616) increased by over 14% as GIC continued to increase its stake, surpassing 7% ownership [1] - Gilead Sciences (01672) rose over 14%, marking five consecutive days of gains, as it develops ASC36 into a monthly therapy [1] - Laika Pharmaceuticals-B (02105) gained 11.96% after securing a significant BD order worth CNY 2.045 billion for a breast cancer target [1] - Yu Yuan Group (00551) rose over 4% due to an increase in shoe prices and potential market share expansion through overseas capacity growth [1] - JS Global Life (01691) increased by 3.5% as a new product from Joyoung became popular, leading to a two-day stock limit increase for Joyoung Co., Ltd. (002242.SZ) [1] - JD Health (06618) rose by 6.8% post-earnings, with a year-on-year operating profit increase of over 125% and strategic partnerships with several well-known pharmaceutical companies [1] Technology Sector - The Hang Seng Tech Index followed the Nasdaq's decline, dropping over 2% [1] - Alibaba fell by 3.46% [1] - Tencent dropped by 0.91% post-earnings [1] Cryptocurrency Sector - Cryptocurrency-related stocks declined, with Boya Interactive (00434) falling over 5% as Bitcoin dropped below the USD 100,000 mark [2]

Core Viewpoint - The Hong Kong stock market experienced a decline, with the Hang Seng Index dropping 1.26% to 26,732 points, and the Hang Seng Tech Index falling 2.20% [1] Sector Performance - The hydrogen energy sector saw significant gains, driven by the National Energy Administration's encouragement of green hydrogen utilization in coal chemical projects. Notable stock performances include: - Reshaping Energy (02570) surged over 55% - Guofu Hydrogen Energy (02582) rose over 11% - Guohong Hydrogen Energy (09663) increased over 5% - Yihuatong (02402) climbed 6.8% [1] Company Highlights - 基石药业-B (02616) increased over 14% as GIC continued to increase its stake, surpassing 7% ownership [1] - 歌礼制药 (01672) rose over 14%, marking five consecutive days of gains, as it develops ASC36 into a monthly therapy [1] - 来凯医药-B (02105) gained 11.96%, securing a significant BD deal worth 2.045 billion yuan in breast cancer treatment [1] - 裕元集团 (00551) saw an increase of over 4%, with third-quarter shoe prices rising and overseas capacity expansion expected to enhance market share [1] - JS环球生活 (01691) rose 3.5%, driven by the popularity of its new soybean milk product [1] - 京东健康 (06618) increased 6.8% post-earnings, with a year-on-year operating profit growth of over 125% and strategic partnerships with several well-known pharmaceutical companies [1] Market Trends - The Hang Seng Tech Index followed the Nasdaq's decline, with major players like Alibaba dropping 3.46% and Tencent falling 0.91% post-earnings [1] - Cryptocurrency-related stocks declined, with 博雅互动 (00434) falling over 5% as Bitcoin dropped below the $100,000 mark [1]

Group 1 - On November 13, Jiuyang Co., Ltd. (002242) experienced a rapid surge, reaching the daily limit for the first time in nearly a year [1] - Jiuyang clarified on an interactive platform that it does not have any products related to "Hachimi" [1] - The company's main business focuses on kitchen small appliances, and it does not engage in food or beverage products [1] Group 2 - On November 11, Jiuyang launched "Hachimi North-South Mung Bean Milk," which sparked significant market discussion [2] - Consumers expressed surprise and interest in Jiuyang's innovative approach to the "Hachimi" trend [2]

Industry Background - In 2025, the food industry is influenced by various factors including policy, economy, social structure, and technology, showcasing unique development trends and consumption patterns [2][4] - The government prioritizes "boosting consumption" as a key task, aiming to transition the food industry from "recovery growth" to "high-quality development" [2][4] - The GDP growth for 2024 is projected at 5%, but the food industry's added value has been declining for four consecutive years, indicating structural supply-demand issues [2][4] - The aging population is accelerating, with those aged 65 and above accounting for 15.6% of the population, while urbanization has reached 67%, shifting consumer dietary preferences from "sufficient" to "quality" [2][4] Core Consumption Trends - Six core consumption trends are identified as new directions for industry development: 1. **Diverse Channel Innovations**: 84.2% of consumers are purchasing alternative products, with retailers optimizing supply chains to lower prices and enhance value [3] 2. **Precision Nutrition Products**: New products targeting different age groups, including senior nutrition and children's dietary needs, are emerging [3] 3. **Emotional Value Experiences**: Marketing strategies focus on sensory and situational engagement, enhancing consumer emotional experiences [3] 4. **Key Demographic Opportunities**: Brands are targeting family nutrition, with rapid growth in urban markets and services for overseas tourists [3] 5. **Smart Information Experiences**: AI is being integrated into product development and production, enhancing personalized nutrition services [3] 6. **Green Revolution in Food and Beverage**: Transparency in supply chains and innovations in green packaging are gaining traction, with over 70% of consumers concerned about "no additives" [3] Strategic Focus for 2025 - The food industry must focus on channel efficiency, precision nutrition, and emotional value, leveraging AI and green technologies to address the needs of the aging population and urban-rural integration [4][5] - The transition from scale expansion to value creation is essential for building a sustainable development ecosystem [4][5]